Clinical Trial Update: Probiotic Visbiome for Inflammation and Translocation in HIV II [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating Visbiome probiotic for inflammation and translocation in HIV infection. The study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Visbiome

Snippet

Sponsor: University Health Network, Toronto | Conditions: HIV-1 Infection | Phase 2 | Status: UNKNOWN